Introduction
Osteoporosis is a condition where the bone becomes more brittle and more likely to break as a person ages. The medicines that people take to treat this condition have prevented many common hip fractures. There is some suspicion that some of these medicines may be associated with problems in the shape and structure of the hip bone after many years of use. These changes in the hip bone are very rare, so it is hard to study them. Researchers want to learn more about these hip bone changes by comparing people who have taken the medicines for a long time with those who have just started to take them and others who have never taken them.
Medicines that we are interested in include:
- Fosamax (alendronate)
- Actonel (risedronate)
- Atelvia (risedronate)
- Boniva (ibandronate)
- Reclast (zoledronate)
If you over the age of 50 and are taking one of these medicines or would like to participate as a healthy volunteer, you may qualify.
To get started:- Navigate through the menu on your left to learn more about the study.
- Log In the application and fill out questionnaires.
